<DOC>
	<DOCNO>NCT01337024</DOCNO>
	<brief_summary>Heart rate variability ( HRV ) important indicator cardiac autonomic function predictor cardiac mortality all-cause mortality . In study investigator examine change HRV patient neurogenic detrusor overactivity ( NDO ) undergo botulinum neurotoxin type A intradetrusor injection ( BoNT/A ) .</brief_summary>
	<brief_title>Heart Rate Variability ( HRV ) Patients With Neurogenic Detrusor Overactivity ( NDO ) Before After Botulinum Neurotoxin Type A ( BoNT/A ) Intradetrusor Injections</brief_title>
	<detailed_description>BoNT/A common treatment patient NDO . Possible known side effect urinary retention increase post void residual . Systemic side effect seem rare . However investigated detail . Although small amount , BoNT/A enter systemic circulation intradetrusor injection might cause distant effect neuro-muscular system , i.e . heart . Aim trial asses potential systemic adverse effect BoNT/A heart follow intradetrusor injection NDO . Potential effect cardiac autonomic function detect use HRV analysis . Patients without relevant preexisting disorder cardiac function proven NDO include . During four separate visit , subject receive two ECG measurement ( Visit 1 2 ) two ECG measurement follow BoNT/A intradetrusor injection ( Visit 3 4 ) . We investigate three different group : 1 ) patient receive BoNT/A intradetrusor injection ( = control group ) , 2 ) patient receive intradetrusor injection 100 unit BoNT/A , 3 ) patient receive intradetrusor injection 300 unit BoNT/A .</detailed_description>
	<mesh_term>Urinary Bladder Diseases</mesh_term>
	<mesh_term>Urinary Bladder , Neurogenic</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<criteria>patient neurogenic detrusor overactivity write informed consent Medical indication BoNT/A injection able learn conduct clean intermittent selfcatheterization No write informed consent Pregnancy Cancer infection lower urinary tract Cardiac pacemaker Previous heart attack , angina pectoris Medication effect HRV Previous cardiosurgery Cardiac arrhythmia Skin disease allow application ECGelectrodes</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>HRV</keyword>
	<keyword>NDO</keyword>
	<keyword>BoNT/A ,</keyword>
	<keyword>adverse effect</keyword>
</DOC>